RCC Flashcards
def of RCC
primary malignancy of the kidney
pathology of RCC
Robson staging
arise from any portion of kidney (usually poles), from proximal reanl tubular epithelium
spherical mass composed of yellow-white tissue, may have necrosis, haemorrhage or calcification
90% adenocarcinomas with small nuclei and abundant clear cytoplasm, other granular cells, occasionally sarcomatoid
rarely, invasion of renal vein compresses L testicular vein = varicocoele
spread is often along the renal vein, with tumour emboli to the lungs
met to lymph nodes, bone liver and skin
aetiology of rcc
renal clear cell carcinomas (80%) or papillary carcinomas (10%) are derived from proximal tubular cells of unknown aetiology
10% are transitional cell carcinomas that occur in renal pelvis
associated with inherited conditions: von hippel-lindau disease, tuberous sclerosis, polycystic kidneys and familial RCC
smoking
obesity
FH
chronic dialysis
chemical exposure (eg benzene, asbestos, trichloroethylene)
RCC can be associated with abnormal LFT in the absence of liver metastases, a phenomenon known as Stauffer’s syndrome
epidemiology of rcc
uncommon approx 3% of all malignancies
M:F 2:1
peak incidence is 40-60yrs
90% of all renal cances
15% haemodialysis pts get RCC
sx of rcc
usually present late (asymptomatic in 90%)
classic triad: haematuria, flank pain, abdo mass (only in 10%)
transitional cell carcinoma - usually present earlier with haematuria
systemic signs of malignancy - weight loss, anorexia, malaise, paraneoplastic syndromes: pyrexia of unknown origin, symptoms of hypercalcaemia or polycythamia
PUO?
signs of rcc
palpable renal mass
hypertension, plethora or anaemia
L sided tumour extending into L renal vein can obstruct the L testicular vein causing L sided varicocele
raised BP because of renin secretion
ix for rcc
- urine dipstick - haematuria, cytology
- Blood - FBC (polycythaemia from erythropoitin secretion), U&E, LFT, high ESR in 75%, ALP (bony mets)
- US abdo - 1st line, distinguish between solid mass and cystic
- KUB and IVU are limited - only detect large lesions that change renal contour or compress ureters
- CT with contrast of MRI more sensitive, staging - ‘cannonball mets’
- bone scan
Management of early-stage RCC (T1 and T2)
surgery for localised
* partial nephrectomy up to 7cm / radical nephrectomy
ablative therapies if high surgical risk
Management of locally advanced RCC (T3 and T4)
radical nephrectomy
Management of metastatic RCC
surgery if good performance status and few isolated sites of disease
low risk: VEGF inhibitors eg sunitinib
immediate/high risk = dual immunotherapy: ipilimumab and nivolumab
complications of renal cell carcinoma
Anaemia (up to 30%)
Hypercalcaemia
Polycythaemia
SIADH
Cushing’s syndrome
Stauffer’s syndrome (liver dysfunction due to paraneoplastic syndrome in the absence of liver metastases)
IVC obstruction due to malignant invasion
Limbic encephalitis: rare disorder characterised by personality changes,, depression, seizures and memory loss.
adverse effects of systemic rx for RCC
Immunotherapy:
* rash,
* pneumonitis,
* colitis,
* thyroid dysfunction
* hypophysitis.
Complications can present over a year after treatment.
VEGF inhibitors:
* mucositis,
* leukopaenia,
* peripheral neuropathy,
* fever,
* arthralgia,
* electrolyte imbalance.
px of renal cell cancer
5yr survival >68%